Avanthi Pharma
Home Contact Us
Home Contact Us
HomeAbout UsNewsGeneric DrugsProductsContact Us
Avanthi Pharma
News

May 12, 2009
Chlorpheniramine Maleate, Extended - Release Tablets (12 mg) Approved by the FDA

March 6, 2009
Indomethacin, Extended - Release Capsules USP (75 mg) Approved by the FDA

Products

1. Indomethacin Extended - Release Capsules USP

Indication: Rheumatoid Arthritis

AB Rated Capsules

Labeler Code Strength Package Size
23520 75 mg 60
23520 75 mg 100
23520 75 mg 500
23520 75 mg 1000

2. Chlorpheniramine Maleate  Extended - Release Tablets

Indication: Allergies

Labeler Code Strength Package Size
23520 12 mg 100
23520 12 mg 24 blister pack